@article{caffb162af744e05b453f733517d74e2,
title = "The magnitude of neurotoxicity in patients with multiple myeloma and the impact of dose modifications: results from the population-based PROFILES registry",
keywords = "Chemotherapy-induced peripheral neuropathy, Neuropathy, Treatment, Dose modification, Multiple myeloma, QUALITY-OF-LIFE, INDUCED PERIPHERAL NEUROPATHY, COMMON TERMINOLOGY CRITERIA, PROTEASOME INHIBITOR, ADVERSE EVENTS, BORTEZOMIB, QUESTIONNAIRE, REVERSIBILITY, DEXAMETHASONE, LENALIDOMIDE",
author = "Beijers, {Antoinetta J. M.} and Simone Oerlemans and Floortje Mols and Marijke Eurelings and Minnema, {Monique C.} and Art Vreugdenhil and {van de Poll-Franse}, {Lonneke V.}",
year = "2017",
month = apr,
doi = "10.1007/s00277-017-2927-8",
language = "English",
volume = "96",
pages = "653--663",
journal = "Annals of Hematology",
issn = "0939-5555",
publisher = "Springer",
number = "4",
}